News | January 12, 2023
H.B. Fuller to launch new bio-compatible adhesive for medical applications
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Swiftmelt 1515-I meets performance requirements and secures skin attachment
The company has played an important role in the procurement and distribution of emergency medical supplies supporting the Union Health Ministry for Covid–19 pandemic management
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public.
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Subscribe To Our Newsletter & Stay Updated
